We examine efforts to correct cost inequities of oral anti-cancer agents through legislation, and we look at further efforts to reduce the cost of oral chemotherapy via cycle management and waste reduction.
Mary Kruczynski
Advertisement
Articles by Mary Kruczynski
The management of patients receiving treatment with oral oncolytics presents challenges such as cost, adherence, monitoring of side effects, and safe handling.
Advertisement
Latest Updated Articles
Oral Oncolytics: Part 1-Financial, Adherence, and Management ChallengesPublished: August 15th 2013 | Updated:
- Oral Oncolytics: Part 2-Legislation Targeting Cost & Access, and Other Initiatives to Reduce Costs
Published: September 15th 2013 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
More Global Expertise and Talent Are Needed to Administer Cell Therapies
2
FDA Grants Priority Review to Enfortumab Vedotin Combo in MIBC Subset
3
Adaptive Treatment and Other Advances May Drive Radiotherapy Field Forward
4
Simultaneous Integrated Boost Radiotherapy Improves PFS in Cervical Cancer
5
